» Articles » PMID: 33850296

Gut Mycobiota Alterations in Patients with COVID-19 and H1N1 Infections and Their Associations with Clinical Features

Overview
Journal Commun Biol
Specialty Biology
Date 2021 Apr 14
PMID 33850296
Citations 47
Authors
Affiliations
Soon will be listed here.
Abstract

The relationship between gut microbes and COVID-19 or H1N1 infections is not fully understood. Here, we compared the gut mycobiota of 67 COVID-19 patients, 35 H1N1-infected patients and 48 healthy controls (HCs) using internal transcribed spacer (ITS) 3-ITS4 sequencing and analysed their associations with clinical features and the bacterial microbiota. Compared to HCs, the fungal burden was higher. Fungal mycobiota dysbiosis in both COVID-19 and H1N1-infected patients was mainly characterized by the depletion of fungi such as Aspergillus and Penicillium, but several fungi, including Candida glabrata, were enriched in H1N1-infected patients. The gut mycobiota profiles in COVID-19 patients with mild and severe symptoms were similar. Hospitalization had no apparent additional effects. In COVID-19 patients, Mucoromycota was positively correlated with Fusicatenibacter, Aspergillus niger was positively correlated with diarrhoea, and Penicillium citrinum was negatively correlated with C-reactive protein (CRP). In H1N1-infected patients, Aspergillus penicilloides was positively correlated with Lachnospiraceae members, Aspergillus was positively correlated with CRP, and Mucoromycota was negatively correlated with procalcitonin. Therefore, gut mycobiota dysbiosis occurs in both COVID-19 patients and H1N1-infected patients and does not improve until the patients are discharged and no longer require medical attention.

Citing Articles

Long COVID and gut microbiome: insights into pathogenesis and therapeutics.

Lau R, Su Q, Ng S Gut Microbes. 2025; 17(1):2457495.

PMID: 39854158 PMC: 11776476. DOI: 10.1080/19490976.2025.2457495.


Characterization of the gut microbiota in patients with SARS-CoV-2 infection during controlled ovarian stimulation.

Yang T, Li G, Yin H, Wu L, Cao Y, Song B J Ovarian Res. 2024; 17(1):231.

PMID: 39568001 PMC: 11577888. DOI: 10.1186/s13048-024-01553-7.


Age-Dependent Changes in Protist and Fungal Microbiota in a Peruvian Cattle Genetic Nucleus.

Estrada R, Romero Y, Quilcate C, Dipaz D, Alejos-Asencio C, Leon S Life (Basel). 2024; 14(8).

PMID: 39202752 PMC: 11355802. DOI: 10.3390/life14081010.


The gut-lung axis: the impact of the gut mycobiome on pulmonary diseases and infections.

Sey E, Warris A Oxf Open Immunol. 2024; 5(1):iqae008.

PMID: 39193472 PMC: 11316619. DOI: 10.1093/oxfimm/iqae008.


Signatures of disease outcome severity in the intestinal fungal and bacterial microbiome of COVID-19 patients.

Rizzello F, Viciani E, Gionchetti P, Filippone E, Imbesi V, Melotti L Front Cell Infect Microbiol. 2024; 14:1352202.

PMID: 38510960 PMC: 10952111. DOI: 10.3389/fcimb.2024.1352202.


References
1.
Sokol H, Leducq V, Aschard H, Pham H, Jegou S, Landman C . Fungal microbiota dysbiosis in IBD. Gut. 2016; 66(6):1039-1048. PMC: 5532459. DOI: 10.1136/gutjnl-2015-310746. View

2.
Samaddar A, Sharma A, Shrimali T . Pulmonary infection due to Acrophialophora fusispora in a patient with underlying mixed connective tissue disease and chronic pulmonary aspergillosis: A case report and review of literature. J Mycol Med. 2020; 30(2):100932. DOI: 10.1016/j.mycmed.2020.100932. View

3.
Kong H, Segre J . Cultivating fungal research. Science. 2020; 368(6489):365-366. PMC: 10506662. DOI: 10.1126/science.aaz8086. View

4.
Lang S, Duan Y, Liu J, Torralba M, Kuelbs C, Ventura-Cots M . Intestinal Fungal Dysbiosis and Systemic Immune Response to Fungi in Patients With Alcoholic Hepatitis. Hepatology. 2019; 71(2):522-538. PMC: 6925657. DOI: 10.1002/hep.30832. View

5.
Liguori G, Lamas B, Richard M, Brandi G, Da Costa G, Hoffmann T . Fungal Dysbiosis in Mucosa-associated Microbiota of Crohn's Disease Patients. J Crohns Colitis. 2015; 10(3):296-305. PMC: 4957473. DOI: 10.1093/ecco-jcc/jjv209. View